Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 314 entries
Sorted by: Best Match Show Resources per page
Reprint of "The role of cytoskeleton in the regulation of vascular endothelial barrier function" [Microvascular Research 76 (2008) 202-207].

Microvascular research

Bogatcheva NV, Verin AD.
PMID: 19232242
Microvasc Res. 2009 Jan;77(1):64-9. doi: 10.1016/S0026-2862(09)00021-1.

The cytoskeleton is vital to the function of virtually all cell types in the organism as it is required for cell division, cell motility, endo- or exocytosis and the maintenance of cell shape. Endothelial cells, lining the inner surface...

Cite
Bogatcheva NV, Verin AD. Reprint of "The role of cytoskeleton in the regulation of vascular endothelial barrier function" [Microvascular Research 76 (2008) 202-207]. Microvasc Res. 2009;77(1):64-9doi: 10.1016/S0026-2862(09)00021-1.
Bogatcheva, N. V., & Verin, A. D. (2009). Reprint of "The role of cytoskeleton in the regulation of vascular endothelial barrier function" [Microvascular Research 76 (2008) 202-207]. Microvascular research, 77(1), 64-9. https://doi.org/10.1016/S0026-2862(09)00021-1
Bogatcheva, Natalia V, and Verin, Alexander D. "Reprint of "The role of cytoskeleton in the regulation of vascular endothelial barrier function" [Microvascular Research 76 (2008) 202-207]." Microvascular research vol. 77,1 (2009): 64-9. doi: https://doi.org/10.1016/S0026-2862(09)00021-1
Bogatcheva NV, Verin AD. Reprint of "The role of cytoskeleton in the regulation of vascular endothelial barrier function" [Microvascular Research 76 (2008) 202-207]. Microvasc Res. 2009 Jan;77(1):64-9. doi: 10.1016/S0026-2862(09)00021-1. PMID: 19232242.
Copy Download .nbib Format: NLM
Corrigendum to "Migration velocity of red blood cells in microchannels" [Microvasc. Res. 124 (2019) 30-36].

Microvascular research

Losserand S, Coupier G, Podgorski T.
PMID: 32143884
Microvasc Res. 2020 May;129:103989. doi: 10.1016/j.mvr.2020.103989. Epub 2020 Mar 03.

No abstract available.

Cite
Losserand S, Coupier G, Podgorski T. Corrigendum to "Migration velocity of red blood cells in microchannels" [Microvasc. Res. 124 (2019) 30-36]. Microvasc Res. 2020;129:103989doi: 10.1016/j.mvr.2020.103989.
Losserand, S., Coupier, G., & Podgorski, T. (2020). Corrigendum to "Migration velocity of red blood cells in microchannels" [Microvasc. Res. 124 (2019) 30-36]. Microvascular research, 129103989. https://doi.org/10.1016/j.mvr.2020.103989
Losserand, Sylvain, et al. "Corrigendum to "Migration velocity of red blood cells in microchannels" [Microvasc. Res. 124 (2019) 30-36]." Microvascular research vol. 129 (2020): 103989. doi: https://doi.org/10.1016/j.mvr.2020.103989
Losserand S, Coupier G, Podgorski T. Corrigendum to "Migration velocity of red blood cells in microchannels" [Microvasc. Res. 124 (2019) 30-36]. Microvasc Res. 2020 May;129:103989. doi: 10.1016/j.mvr.2020.103989. Epub 2020 Mar 03. PMID: 32143884.
Copy Download .nbib Format: NLM
Corrigendum to "Endocan is useful biomarker of survival and severity in sepsis" [Microvasc. Res. 93 (2014) 92-97].

Microvascular research

Mihajlovic DM, Lendak DF, Draskovic BG, Brkic SV, Mitic GP, Novakov Mikic AS, Cebovic TN.
PMID: 32122635
Microvasc Res. 2020 May;129:103992. doi: 10.1016/j.mvr.2020.103992. Epub 2020 Feb 29.

No abstract available.

Cite
Mihajlovic DM, Lendak DF, Draskovic BG, et al. Corrigendum to "Endocan is useful biomarker of survival and severity in sepsis" [Microvasc. Res. 93 (2014) 92-97]. Microvasc Res. 2020;129:103992doi: 10.1016/j.mvr.2020.103992.
Mihajlovic, D. M., Lendak, D. F., Draskovic, B. G., Brkic, S. V., Mitic, G. P., Novakov Mikic, A. S., & Cebovic, T. N. (2020). Corrigendum to "Endocan is useful biomarker of survival and severity in sepsis" [Microvasc. Res. 93 (2014) 92-97]. Microvascular research, 129103992. https://doi.org/10.1016/j.mvr.2020.103992
Mihajlovic, Dunja M, et al. "Corrigendum to "Endocan is useful biomarker of survival and severity in sepsis" [Microvasc. Res. 93 (2014) 92-97]." Microvascular research vol. 129 (2020): 103992. doi: https://doi.org/10.1016/j.mvr.2020.103992
Mihajlovic DM, Lendak DF, Draskovic BG, Brkic SV, Mitic GP, Novakov Mikic AS, Cebovic TN. Corrigendum to "Endocan is useful biomarker of survival and severity in sepsis" [Microvasc. Res. 93 (2014) 92-97]. Microvasc Res. 2020 May;129:103992. doi: 10.1016/j.mvr.2020.103992. Epub 2020 Feb 29. PMID: 32122635.
Copy Download .nbib Format: NLM
Improvement of tube formation model of cell: Application for acute hypoxia in in vitro study of angiogenesis.

Microvascular research

Li F, Gou X, Xu D, Han D, Hou K, Fang W, Li Y.
PMID: 34890690
Microvasc Res. 2021 Dec 07;140:104297. doi: 10.1016/j.mvr.2021.104297. Epub 2021 Dec 07.

Angiogenesis caused by acute vascular occlusion occurs in various ischemic diseases. The in vitro tube formation assay by endothelial cells is a rapid, quantitative method for drug discovery on angiogenesis. Tube formation assay on Matrigel has been widely used...

Cite
Li F, Gou X, Xu D, et al. Improvement of tube formation model of cell: Application for acute hypoxia in in vitro study of angiogenesis. Microvasc Res. 2021;140:104297doi: 10.1016/j.mvr.2021.104297.
Li, F., Gou, X., Xu, D., Han, D., Hou, K., Fang, W., & Li, Y. (2021). Improvement of tube formation model of cell: Application for acute hypoxia in in vitro study of angiogenesis. Microvascular research, 140104297. https://doi.org/10.1016/j.mvr.2021.104297
Li, Fengyang, et al. "Improvement of tube formation model of cell: Application for acute hypoxia in in vitro study of angiogenesis." Microvascular research vol. 140 (2021): 104297. doi: https://doi.org/10.1016/j.mvr.2021.104297
Li F, Gou X, Xu D, Han D, Hou K, Fang W, Li Y. Improvement of tube formation model of cell: Application for acute hypoxia in in vitro study of angiogenesis. Microvasc Res. 2021 Dec 07;140:104297. doi: 10.1016/j.mvr.2021.104297. Epub 2021 Dec 07. PMID: 34890690.
Copy Download .nbib Format: NLM
Two new applications in the study of angiogenesis the CAM assay: Acellular scaffolds and organoids.

Microvascular research

Ribatti D.
PMID: 34906560
Microvasc Res. 2021 Dec 11;140:104304. doi: 10.1016/j.mvr.2021.104304. Epub 2021 Dec 11.

The chick embryo chorioallantoic membrane (CAM) is a rich vascularized extraembryonic membrane that is commonly used as an in vivo experimental model to study molecules with angiogenic and anti-angiogenic activity, tumor growth and metastasis. Among other applications of the...

Cite
Ribatti D. Two new applications in the study of angiogenesis the CAM assay: Acellular scaffolds and organoids. Microvasc Res. 2021;140:104304doi: 10.1016/j.mvr.2021.104304.
Ribatti, D. (2021). Two new applications in the study of angiogenesis the CAM assay: Acellular scaffolds and organoids. Microvascular research, 140104304. https://doi.org/10.1016/j.mvr.2021.104304
Ribatti, Domenico. "Two new applications in the study of angiogenesis the CAM assay: Acellular scaffolds and organoids." Microvascular research vol. 140 (2021): 104304. doi: https://doi.org/10.1016/j.mvr.2021.104304
Ribatti D. Two new applications in the study of angiogenesis the CAM assay: Acellular scaffolds and organoids. Microvasc Res. 2021 Dec 11;140:104304. doi: 10.1016/j.mvr.2021.104304. Epub 2021 Dec 11. PMID: 34906560.
Copy Download .nbib Format: NLM
Intrauterine growth restriction neonates present with increased angiogenesis through the Notch1 signaling pathway.

Microvascular research

Li M, Zhang Z, Joynauth J, Zhan X, Du L.
PMID: 34995552
Microvasc Res. 2022 Jan 04;140:104308. doi: 10.1016/j.mvr.2021.104308. Epub 2022 Jan 04.

Intrauterine growth restriction (IUGR) is associated with increased perinatal mortality and morbidity, and plays an important role in the development of adult cardiovascular diseases. This study brings forward a hypothesis that Human umbilical vein endothelial cells (HUVECs) from IUGR...

Cite
Li M, Zhang Z, Joynauth J, et al. Intrauterine growth restriction neonates present with increased angiogenesis through the Notch1 signaling pathway. Microvasc Res. 2022;140:104308doi: 10.1016/j.mvr.2021.104308.
Li, M., Zhang, Z., Joynauth, J., Zhan, X., & Du, L. (2022). Intrauterine growth restriction neonates present with increased angiogenesis through the Notch1 signaling pathway. Microvascular research, 140104308. https://doi.org/10.1016/j.mvr.2021.104308
Li, Min, et al. "Intrauterine growth restriction neonates present with increased angiogenesis through the Notch1 signaling pathway." Microvascular research vol. 140 (2022): 104308. doi: https://doi.org/10.1016/j.mvr.2021.104308
Li M, Zhang Z, Joynauth J, Zhan X, Du L. Intrauterine growth restriction neonates present with increased angiogenesis through the Notch1 signaling pathway. Microvasc Res. 2022 Jan 04;140:104308. doi: 10.1016/j.mvr.2021.104308. Epub 2022 Jan 04. PMID: 34995552.
Copy Download .nbib Format: NLM
Post-occlusive reactive hyperemia and skeletal muscle capillary hemodynamics.

Microvascular research

Horn AG, Schulze KM, Weber RE, Barstow TJ, Musch TI, Poole DC, Behnke BJ.
PMID: 34822837
Microvasc Res. 2021 Nov 22;140:104283. doi: 10.1016/j.mvr.2021.104283. Epub 2021 Nov 22.

Post-occlusive reactive hyperemia (PORH) is an accepted diagnostic tool for assessing peripheral macrovascular function. While conduit artery hemodynamics have been well defined, the impact of PORH on capillary hemodynamics remains unknown, despite the microvasculature being the dominant site of...

Cite
Horn AG, Schulze KM, Weber RE, et al. Post-occlusive reactive hyperemia and skeletal muscle capillary hemodynamics. Microvasc Res. 2021;140:104283doi: 10.1016/j.mvr.2021.104283.
Horn, A. G., Schulze, K. M., Weber, R. E., Barstow, T. J., Musch, T. I., Poole, D. C., & Behnke, B. J. (2021). Post-occlusive reactive hyperemia and skeletal muscle capillary hemodynamics. Microvascular research, 140104283. https://doi.org/10.1016/j.mvr.2021.104283
Horn, Andrew G, et al. "Post-occlusive reactive hyperemia and skeletal muscle capillary hemodynamics." Microvascular research vol. 140 (2021): 104283. doi: https://doi.org/10.1016/j.mvr.2021.104283
Horn AG, Schulze KM, Weber RE, Barstow TJ, Musch TI, Poole DC, Behnke BJ. Post-occlusive reactive hyperemia and skeletal muscle capillary hemodynamics. Microvasc Res. 2021 Nov 22;140:104283. doi: 10.1016/j.mvr.2021.104283. Epub 2021 Nov 22. PMID: 34822837.
Copy Download .nbib Format: NLM
Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation.

Microvascular research

Jiang B, Wang M, Li X, Ren P, Li G, Wang Y, Wang L, Li X, Yang D, Qin L, Xin S.
PMID: 34856183
Microvasc Res. 2021 Nov 29;140:104280. doi: 10.1016/j.mvr.2021.104280. Epub 2021 Nov 29.

Hexarelin, a synthetic growth hormone-releasing peptide, is shown to be protective in cardiovascular diseases such as myocardial infraction and atherosclerosis. However, the functional role of hexarelin in abdominal aortic aneurysm (AAA) remains undefined. The present study determined the effect...

Cite
Jiang B, Wang M, Li X, et al. Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation. Microvasc Res. 2021;140:104280doi: 10.1016/j.mvr.2021.104280.
Jiang, B., Wang, M., Li, X., Ren, P., Li, G., Wang, Y., Wang, L., Li, X., Yang, D., Qin, L., & Xin, S. (2021). Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation. Microvascular research, 140104280. https://doi.org/10.1016/j.mvr.2021.104280
Jiang, Bo, et al. "Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation." Microvascular research vol. 140 (2021): 104280. doi: https://doi.org/10.1016/j.mvr.2021.104280
Jiang B, Wang M, Li X, Ren P, Li G, Wang Y, Wang L, Li X, Yang D, Qin L, Xin S. Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation. Microvasc Res. 2021 Nov 29;140:104280. doi: 10.1016/j.mvr.2021.104280. Epub 2021 Nov 29. PMID: 34856183.
Copy Download .nbib Format: NLM
A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.

Microvascular research

Hou S, Niu G, Liu X, Bourbon PM, Zhang D, Cui P, Zhao K, Zhao D, Zeng H.
PMID: 34146582
Microvasc Res. 2021 Nov;138:104209. doi: 10.1016/j.mvr.2021.104209. Epub 2021 Jun 16.

Angiogenesis is critical for many diseases. Previously, we reported that Down Syndrome Candidate Region 1 isoform 1L (DSCR1-1L) was one of the most up-regulated genes in endothelial cells induced by VEGF and histamine, and regulated endothelial cell proliferation and...

Cite
Hou S, Niu G, Liu X, et al. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis. Microvasc Res. 2021;138:104209doi: 10.1016/j.mvr.2021.104209.
Hou, S., Niu, G., Liu, X., Bourbon, P. M., Zhang, D., Cui, P., Zhao, K., Zhao, D., & Zeng, H. (2021). A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis. Microvascular research, 138104209. https://doi.org/10.1016/j.mvr.2021.104209
Hou, Shiqiang, et al. "A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis." Microvascular research vol. 138 (2021): 104209. doi: https://doi.org/10.1016/j.mvr.2021.104209
Hou S, Niu G, Liu X, Bourbon PM, Zhang D, Cui P, Zhao K, Zhao D, Zeng H. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis. Microvasc Res. 2021 Nov;138:104209. doi: 10.1016/j.mvr.2021.104209. Epub 2021 Jun 16. PMID: 34146582.
Copy Download .nbib Format: NLM
Definition and application of proximal-distal gradient finger perfusion in systemic sclerosis by laser speckle contrast analysis.

Microvascular research

Di Battista M, Morganti R, Tani E, Da Rio M, Rossa AD, Mosca M.
PMID: 34971696
Microvasc Res. 2021 Dec 28;104307. doi: 10.1016/j.mvr.2021.104307. Epub 2021 Dec 28.

OBJECTIVE: In patients with systemic sclerosis (SSc) the perfusion of the fingers shows an alteration of the physiological proximal-distal gradient (PDG). The aim of this study is to provide a generalizable definition of PDG, applying it in a cohort...

Cite
Di Battista M, Morganti R, Tani E, et al. Definition and application of proximal-distal gradient finger perfusion in systemic sclerosis by laser speckle contrast analysis. Microvasc Res. 2021;104307doi: 10.1016/j.mvr.2021.104307.
Di Battista, M., Morganti, R., Tani, E., Da Rio, M., Rossa, A. D., & Mosca, M. (2021). Definition and application of proximal-distal gradient finger perfusion in systemic sclerosis by laser speckle contrast analysis. Microvascular research, 104307. https://doi.org/10.1016/j.mvr.2021.104307
Di Battista, Marco, et al. "Definition and application of proximal-distal gradient finger perfusion in systemic sclerosis by laser speckle contrast analysis." Microvascular research vol. (2021): 104307. doi: https://doi.org/10.1016/j.mvr.2021.104307
Di Battista M, Morganti R, Tani E, Da Rio M, Rossa AD, Mosca M. Definition and application of proximal-distal gradient finger perfusion in systemic sclerosis by laser speckle contrast analysis. Microvasc Res. 2021 Dec 28;104307. doi: 10.1016/j.mvr.2021.104307. Epub 2021 Dec 28. PMID: 34971696.
Copy Download .nbib Format: NLM
Heterogeneity of nanomechanical properties of the human umbilical vein endothelial cell surface.

Microvascular research

Starodubtseva MN, Nadyrov EA, Shkliarava NM, Tsukanava AU, Starodubtsev IE, Kondrachyk AN, Matveyenkau MV, Nedoseikina MS.
PMID: 33845104
Microvasc Res. 2021 Jul;136:104168. doi: 10.1016/j.mvr.2021.104168. Epub 2021 Apr 09.

Endothelial cells, due to heterogeneity in the cell structure, can potentially form an inhomogeneous on structural and mechanical properties of the inner layer of the capillaries. Using quantitative nanomechanical mapping mode of atomic force microscopy, the parameters of the...

Cite
Starodubtseva MN, Nadyrov EA, Shkliarava NM, et al. Heterogeneity of nanomechanical properties of the human umbilical vein endothelial cell surface. Microvasc Res. 2021;136:104168doi: 10.1016/j.mvr.2021.104168.
Starodubtseva, M. N., Nadyrov, E. A., Shkliarava, N. M., Tsukanava, A. U., Starodubtsev, I. E., Kondrachyk, A. N., Matveyenkau, M. V., & Nedoseikina, M. S. (2021). Heterogeneity of nanomechanical properties of the human umbilical vein endothelial cell surface. Microvascular research, 136104168. https://doi.org/10.1016/j.mvr.2021.104168
Starodubtseva, Maria N, et al. "Heterogeneity of nanomechanical properties of the human umbilical vein endothelial cell surface." Microvascular research vol. 136 (2021): 104168. doi: https://doi.org/10.1016/j.mvr.2021.104168
Starodubtseva MN, Nadyrov EA, Shkliarava NM, Tsukanava AU, Starodubtsev IE, Kondrachyk AN, Matveyenkau MV, Nedoseikina MS. Heterogeneity of nanomechanical properties of the human umbilical vein endothelial cell surface. Microvasc Res. 2021 Jul;136:104168. doi: 10.1016/j.mvr.2021.104168. Epub 2021 Apr 09. PMID: 33845104.
Copy Download .nbib Format: NLM
Kawasaki disease and increased cardiovascular risk: Is there a link to circulating glycocalyx biomarkers?.

Microvascular research

Jakob A, Bohlig S, König M, Nussbaum C, Dalla-Pozza R, Hermann M, Haas NA, Pastor-Villaescusa B.
PMID: 34699846
Microvasc Res. 2021 Oct 23;140:104269. doi: 10.1016/j.mvr.2021.104269. Epub 2021 Oct 23.

AIMS: Kawasaki disease (KD) is an acute systemic vasculitis with possible long-term impact of general cardio-vascular health. An endothelial glycocalyx disorder during the disease's acute phase might predispose to long-term vascular anomalies leading to endothelial dysfunction and atherosclerosis. To...

Cite
Jakob A, Bohlig S, König M, et al. Kawasaki disease and increased cardiovascular risk: Is there a link to circulating glycocalyx biomarkers?. Microvasc Res. 2021;140:104269doi: 10.1016/j.mvr.2021.104269.
Jakob, A., Bohlig, S., König, M., Nussbaum, C., Dalla-Pozza, R., Hermann, M., Haas, N. A., & Pastor-Villaescusa, B. (2021). Kawasaki disease and increased cardiovascular risk: Is there a link to circulating glycocalyx biomarkers?. Microvascular research, 140104269. https://doi.org/10.1016/j.mvr.2021.104269
Jakob, André, et al. "Kawasaki disease and increased cardiovascular risk: Is there a link to circulating glycocalyx biomarkers?." Microvascular research vol. 140 (2021): 104269. doi: https://doi.org/10.1016/j.mvr.2021.104269
Jakob A, Bohlig S, König M, Nussbaum C, Dalla-Pozza R, Hermann M, Haas NA, Pastor-Villaescusa B. Kawasaki disease and increased cardiovascular risk: Is there a link to circulating glycocalyx biomarkers?. Microvasc Res. 2021 Oct 23;140:104269. doi: 10.1016/j.mvr.2021.104269. Epub 2021 Oct 23. PMID: 34699846.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 314 entries